GoodRx Holdings Board Restructure and New Director Induction
Company Announcements

GoodRx Holdings Board Restructure and New Director Induction

The latest announcement is out from GoodRx Holdings (GDRX).

GoodRx Holdings, Inc. has announced the election of Ian T. Clark to its Board of Directors, filling the vacancy left by Stephen LeSieur. Clark, deemed independent under Nasdaq rules, will serve as a Class III director until the 2026 Annual Meeting and has been appointed Chair of the Innovation Committee. He has received stock-based compensation worth over $600,000 subject to continued service, in line with the company’s director compensation program. Additionally, the Board has restructured its committees, merging the Audit and Compliance Committees into a single Audit and Risk Committee and establishing a new Innovation Committee.

See more insights into GDRX stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyGoodRx management to meet virtually with KeyBanc
TheFlyGoodRx price target lowered to $8 from $9 at Deutsche Bank
TipRanks Auto-Generated NewsdeskGoodRx Holdings Reports Strong Q3 2024 Performance
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App